Guselkumab
Guselkumab is a biologic medication that works by blocking IL-23, a cytokine that is responsible for inflammation. Guselkumab also binds to CD64, a receptor on cells that produce IL-23.
Nufactor carries the following guselkumab brand:
Brand (Manufacturer)
FDA-approved indication(s) [abbreviated]
FDA-approved indication(s) [abbreviated]:
- Crohn’s Disease
- Plaque Psoriasis
- Psoriatic Arthritis
- Ulcerative Colitis
Last reviewed 01/15/2026
The information provided on this website is not medical advice, nor is it intended to be a substitute for medical advice, diagnosis, and treatment. Always seek the advice of a physician or other qualified health provider with questions concerning a medical condition. Never disregard professional medical advice, or delay seeking it based on information provided on this website.
